natgillin/translations-raw huggingface dataset:
Method for the immunological determination of an antibody against the amyloid β peptide in a sample using an immunoassay employing an antibody obtained from cell line DSM ACC2939, wherein the immunoassay comprises a capture antibody, a tracer antibody and a detection antibody, wherein said capture antibody is a biotinylated anti-idiotype antibody against an antibody against the amyloid β peptide obtained from cell line DSM ACC2939 conjugated to a solid phase via streptavidin, said tracer antibody is an anti-idiotype antibody against an antibody against the amyloid β peptide obtained from cell line DSM ACC2939 conjugated to digoxygenin as detectable label, and said detection antibody is an antibody against digoxygenin conjugated to a peroxidase. 
Postupak za imunološko određivanje protutijela za amiloid-β-peptid, naznačen time, da se provodi u uzorku uporabom imunološke analize koja se primjenjuje na protutijelu koje se dobiva iz stanične linije DSM ACC2939, pri čemu imunološka analiza obuhvaća protutijelo za hvatanje, protutijelo za traganje i protutijelo za otkrivanje, dok spomenuto protutijelo za hvatanje je biotinilirano anti-idiotipično protutijelo koje je protiv protutijela za amiloid-β-peptid, dobiveno iz stanične linije DSM ACC2939, i konjugirano preko streptavidina na krutu fazu, gdje protutijelo za traganje je anti-idiotipično protutijelo koje je protiv protutijela za amiloid-β-peptid, dobiveno iz stanične linije DSM ACC2939, i konjugirano na digoksigenin koji služi kao oznaka koja se može otkrivati, te spomenuto protutijelo za otkrivanje je protutijelo protiv digoksigenina, konjugirano na peroksidazu.
Method for the immunological determination of an antibody against the amyloid β peptide in a sample using an immunoassay employing an antibody obtained from cell line DSM ACC2939, wherein the immunoassay comprises the amyloid P peptide conjugated to a solid phase, an anti-idiotype antibody against an antibody against the amyloid β peptide obtained from cell line DSM ACC2939 conjugated to digoxygenin as detectable label, and a detection antibody against digoxygenin conjugated to a peroxidase. 
Postupak za imunološko određivanje protutijela za amiloid-β-peptid, naznačen time, da se provodi u uzorku uporabom imunološke analize koja se primjenjuje na protutijelu koje se dobiva iz stanične linije DSM ACC2939, pri čemu imunološka analiza obuhvaća amiloid-β-peptid konjugiran na krutu fazu, anti-idiotipično protutijelo koje je protiv protutijela za amiloid-β-peptid, dobiveno iz stanične linije DSM ACC2939, konjugirano na digoksigenin koji služi kao oznaka koja se može otkrivati, te protutijelo za otkrivanje protiv digoksigenina, konjugirano na peroksidazu.
A washing brush assembly, according to claim 1, characterized in that said plate body is made of a closed cell foamed plastics material, a felt, fabric, non-woven or other materials. 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što je ravno tijelo načinjeno od plastičnog pjenastog materijala tijesno stisnutih stanica, filca, tkanine, koja nije tkana ili drugih materijala.
A washing brush assembly, according to claim 1, characterized in that said plate body (2, 44, 45) is made of a foamed polyethylene, EVA or any other flexible foamed materials either of a closed cell or a non-closed cell type, or a fabric material, a woven or non-woven fabric material, or any combinations of said materials. 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što je navedeno tijelo (2, 44, 45) načinjeno od pjenastog polietilena, EVA ili bilo kojeg drugog fleksibilnog pjenastog materijala zatvorenih stanica ili nezatvorenih stanica, ili tekstilnog materijala, tkanog ili ne tkanog materijala, ili bilo kojih kombinacija navedenih materijala.
A washing brush assembly, according to claim 1, characterized in that said plate body is bent through 180° about a cross axis thereof to provide two sectors, which are overlapped, in a use configuration, with the cleaning elements applied to a central washing brush assembly shaft; or said plate body (2, 44, 45) is at first bent on itself, along a longitudinal axis, and then through 180° about a cross axis thereof, to provide two cup sectors arranged in an adjoining relationship, in a use configuration, with cleaning elements applied to a central shaft of a washing brush assembly. 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što je navedeno tijelo svinuto za 180° oko poprečne osi kako bi omogućilo dva sektora, koji se preklapaju, u uporabi u konfiguraciji, s elementima za čišćenje pričvršćenim na središnju osovinu sklopa za čišćenje; ili je navedeno tijelo (2, 44, 45) najprije samostalno svinuto, duž longitudinalne osi, i zatim za 180° oko njegove poprečne osi, kako bi nastala dva sektora koji se dodiruju, u uporabi u konfiguraciji, s elementima za čišćenje pričvršćenim na središnju osovinu sklopa za čišćenje.
A washing brush assembly, according to one or more of the preceding claims, characterized in that said washing brush assembly comprises a brush wash assembly battery the washing brush assemblies of which are arranged on a horizontal axis and divided into a single central body, closed, at the side portions thereof, by two cut-through band elements, said central body providing a delicate washing and including a plurality of said washing brush assemblies, each of which comprises a plurality of said band elements, including short strips or strips being arranged in an offset position. 
Sklop četki za pranje, sukladno jednom ili više prethodnih zahtjeva, naznačen time što sklop četki za pranje obuhvaća bateriju sklopova četki za pranje koje su organizirane na horizontalnoj osi i podijeljene u jedno središnje tijelo, zatvoreno, na njegovim bočnim dijelovima, pomoću dva prorezana elementa, središnje tijelo pruža pranje blagom silom i uključuje više sklopova četki za pranje, svaki od kojih obuhvaća više elemenata, uključujući kratke trake ili trake organizirane u pomaknutom položaju.
A washing brush assembly, according to claim 1, characterized in that said plate body (2) has an elongated configuration, according to a longitudinal axis of said bands and being provided with cut-outs (5) defining a plurality of triangular strips (4) having either bevelled and/or non-bevelled corner portions. 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što tijelo (2) ima izduženu konfiguraciju, sukladno longitudinalnoj osi i ima izreske (5) određujući više trokutastih traka (4) sa zašiljenim i/ili nezašiljenim kutnim položajima.
A washing brush assembly, according to claim 1, characterized in that the central cleaning element does not comprise said strips (5). 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što središnji element za čišćenje ne obuhvaća navedene trake (5).
A washing brush assembly, according to claim 1, characterized in that the bottom sector (11) provides an enhanced washing force and comprises a plurality of washing brush assemblies including eighteen said bands (21), with corresponding strips (4) having a n equal length. 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što donji sektor (11) omogućava pojačanu silu pranja i obuhvaća više sklopova četki za pranje uključujući osamnaest navedenih elemenata (21), s odgovarajućim trakama (4) jednake duljine.
A washing brush assembly, according to claim 1, characterized in that said central sector (12) provides a delicate washing force and comprises a plurality of washing brush assemblies including twelve bands (22), comprising corresponding shaft strips (4) having a small length and being arranged in an offset position. 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što središnji sektor (12) pruža blagu silu pranja i obuhvaća više sklopova četki za pranje uključujući dvanaest elemenata (22), koji obuhvaćaju odgovarajuće trake (4) male duljine i nagnutog položaja.
A washing brush assembly, according to one or more of the preceding claims, characterized in that each said cleaning band element comprises both a tip washing portion and a central washing portion, said washing portions providing an enhanced contact surface with said motor vehicle body. 
Sklop četki za pranje, sukladno jednom ili više prethodnih zahtjeva, naznačen time što svaki element za pranje obuhvaća gornji i središnji dio za pranje, navedeni dijelovi za pranje omogućuju pojačani kontakt s površinom motornog vozila.
A washing brush assembly, according to claim 1, characterized in that said washing brush assembly comprises a construction made of half-flag elements (44, 45) so overlapped onto one another thereby providing an inner structural rib of said washing brush assembly providing an enhanced strength and stiffness both in an operating and in a rest condition of said washing brush assembly. 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što sklop četki za pranje obuhvaća konstrukciju načinjenu od elemenata oblika trokutastih zastavica (44, 45) preklopljenih na način da pružaju unutarnje strukturalno rebro sklopa četki za pranje pružajući pojačanu snagu i čvrstoću u operativnom i stanju mirovanja sklopa četki za pranje.
A washing brush assembly, according to claim 1, characterized in that said flags (44, 45) are arranged in a plastics material shaft (42) and are clamped, by clamping thermowelded plug elements. 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što su navedene zastavice (44, 45) organizirane u osovini od plastičnog materijala (42) i spojene, pomoću toplinski zavarenih dodataka.
A washing brush assembly, according to claim 1, characterized in that said washing brush assembly comprises two die-cut half-flags (44, 45) having a like size and shape, so overlapped as to cause corresponding clamping holes (46) thereof to also overlap. 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što sklop četki za pranje obuhvaća dvije izrezane polu-zastave oblika trokuta (44, 45) slične veličine i oblika, preklopljene na način da nastanu rupe za pričvršćivanje (46) koje se također preklapaju.
A washing brush assembly, according to claim 1, characterized in that said half-flags are both bent in half through 90° along a longitudinal axis thereof and are then further bent through 90° along a cross axis thereof passing through said clamping holes. 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što su navedene polu-zastave obje svinute pod kutem od 90° duž longitudinalne osi i nadalje svinute za 90° duž poprečne osi koja prolazi kroz rupe za pričvršćivanje.
A washing brush assembly, according to claim 1, characterized in that said flags define a flag block (43) to be arranged on a corresponding shaft and that said block (43) is clamped to a support post, thereby providing structural cup elements (48) for reinforcing the bristle bottom. 
Sklop četki za pranje, sukladno zahtjevu 1, naznačen time što navedene zastave određuju blok zastava (43) koji će biti organiziran na odgovarajućoj osovini i navedeni blok (43) je pričvršćen za potporni stup, omogućavajući time strukturalne elemente (48) za jačanje dna četke.
An expansion turbine for apparatuses for producing energy through an Organic Rankine Cycle (ORC) or a Kalina cycle, comprising: 
Ekspanzijska turbina za uređaje za proizvodnju energije kroz Organic Rankine (ORC) ciklus ili Kalina ciklus, sadrži:
a case having an inlet and an outlet for a working fluid; 
kućište s ulazom i izlazom za radnu tekućinu;
a short-pipe (4) constrained to the case; 
kratka cijev (4) vezana za kućište;
A turbine as claimed in claim 1, comprising a self-centring joint (11, 12) connecting the shaft (6) and the rotor (2). 
Turbina sukladno zahtjevu 1, obuhvaća samocentrirajući spoj (11, 12) koji spaja osovinu (6) i rotor (2).
A turbine as claimed in claim 2, wherein the self- centring joint (11, 12) is of the toothed-coupling type. 
Turbina sukladno zahtjevu 2, pri čemu je samocentrirajući zglob (11, 12) tipa nazubljene spojke.
A turbine as claimed in claim 4, comprising a spherical coupling (15, 16) connecting the tie-rod (14) and the rotor (2). 
Turbina sukladno zahtjevu 4, obuhvaća sferični spoj (15, 16) koji spaja sponu (14) i rotor (2).
A turbine as claimed in claim 1, further comprising devices for locking the rotor (2) against the short-pipe (4) when said rotor (2) is in the second configuration. 
Turbina sukladno zahtjevu 1, nadalje obuhvaća uređaje za zaključavanje rotora (2) za kratku cijev (4) kada je rotor (2) u drugoj konfiguraciji.
A turbine as claimed in claim 1, wherein the mechanical unit (5) comprises rolling bearings (8) rotatably supporting the shaft (6) inside the bushing (7). 
Turbina sukladno zahtjevu 1, pri čemu mehanička jedinica (5) obuhvaća kuglične ležajeve (8) koji rotatabilno podupiru vratilo (6) unutar čahure (7).
locking the rotor (2) against the short-pipe (4); 
zaključavanje rotora (2) uz kratku cijev (4);
extracting the mechanical unit (5) from the short- pipe (4) while the rotor (2) is being locked against said short-pipe (4). 
izdvajanje mehaničke jedinice (5) od kratke cijevi (4) dok se rotor (2) zaključava uz kratku cijev (4).
Antibody according to claim 1 to 2, whereby the antibody consists of an antigen-binding region that binds specifically to or has a high affinity of for one or more regions of PRLR, whose amino acid sequence is depicted by SEQ ID NO: 70 and human polymorphic variants of SEQ ID NO: 70, amino acid position 1 to 210, whereby the affinity is at least 100 nM, preferably less than about 100 nM, more preferably less than about 30 nM, even more preferred with an affinity of less than about 10 nM, or even more preferred with an affinity of less than 1 nM. 
Antitijelo i fragment koji veže antigen prema zahtjevu 1 i 2, naznačeno time da se antitijelo sastoji od područja koje veže antigen koje se specifično veže na ili ima visoki afinitet za jednu ili više regija od PRLR, navedena sekvenca amino kiseline je prikazana sa SEQ ID NO: 70 i ljudskim polimorfnim varijantama iz SEQ ID NO: 70, položajem amino kiseline 1 do 210, pri čemu je afinitet barem 30 nM, poželjnije s afinitetom od manje od oko 10 nM, ili čak još poželjnije s afinitetom od manje od 1 nM.
Expression vector comprising a nucleic acid sequence of claim 5. 
Ekspresijski vektor naznačen time da sadrži sekvencu nukleinske kiseline prema zahtjevu 5.
Host cell comprising the vector of claim 6 or a nucleic acid molecule of claim 5, whereby the host cell can be a higher eukaryotic host cell, such as a mammalian cell, a lower eukaryotic host cell, such as a yeast cell, and may be a prokaryotic cell, such as a bacterial cell. 
Stanica domaćin, naznačena time da sadrži vektor prema zahtjevu 6 ili molekulu nukleinske kiseline prema zahtjevu 5, pri čemu stanica domaćin je viša eukariotska stanica domaćin, niža eukariotska stanica domaćin, ili prokariotska stanica. Stanica domaćin prema zahtjevu 7, naznačena time da viša eukariotska stanica domaćin je stanica sisavca.
Antibody or antigen-binding fragment according to any of claims 1 to 4 for use as a medicament for the treatment and/or prevention of endometriosis and adenomyosis (endometriosis interna). 
Antitijelo ili fragment koji veže antigen prema bilo kojem od zahtjeva 1 do 4 naznačeno time da je za uporabu kao lijek za liječenje i/ili prevenciju endometrioze i adenomioze (endometriosis interna).
The pharmaceutical composition according to claim 8 for use in preventing or treating central nervous system diseases. 
Farmaceutski pripravak prema zahtjevu 7 naznačen time da je za uporabu u sprječavanju ili liječenju bolesti središnjeg živčanog sustava.
The combination for use according to claim 14, wherein the additional therapeutic agent is an atypical antipsychotic. 
Kombinacija za uporabu prema zahtjevu 13, naznačena time da je dodatno terapeutsko sredstvo atipični antipsihotik.
The combination for use according to claim 14, wherein the additional therapeutic agent is selected from the group consisting of aripiprazole, clozapine, ziprasidone, risperidone, quetiapine, olanzapine, amisulpride, asenapine, iloperidone, melperone, paliperidone, perospirone, sertindole and sulpride. 
Kombinacija za uporabu prema zahtjevu 13, naznačena time da je dodatno terapeutsko sredstvo je odabrano iz skupine koju čine aripiprazol, klozapin, ziprasidon, risperidon, kvetiapin, olanzapin, amisulprid, asenapin, iloperidon, melperon, paliperidon, perospiron, sertindol i sulprid.
The combination for use according to claim 14, wherein the additional therapeutic agent is a typical antipsychotic. 
Kombinacija za uporabu prema zahtjevu 13, naznačena time da je dodatno terapeutsko sredstvo tipični antipsihotik.
The combination for use according to claim 13, wherein the additional therapeutic agent is selected from the group consisting of haloperidol, molindone, loxapine, thioridazine, thiothixene, pimozide, fluphenazine, trifluoperazine, mesoridazine, chlorprothixene, chlorpromazine, perphenazine, triflupromazine and zuclopenthixol. 
Kombinacija za uporabu prema zahtjevu 13, naznačena time da je dodatno terapeutsko sredstvo je odabrano iz skupine koju čine haloperidol, molindon, loksapin, tioridazin, tiotiksen, pimozid, flufenazin, trifluoperazin, mesoridazin, klorprotiksen, klorpromazin, perfenazin, triflupromazin i zuklopentiksol.
The pharmaceutical composition or kit of parts for use according to claim 1, wherein the compound has higher affinity and/or receptor activation efficacy for the 5-HT1 D receptor compared to the 5-HT1 B and 5-HT1 F receptors. 
Farmaceutski pripravak ili set dijelova za uporabu prema zahtjevu 1, gdje spoj ima veći afinitet i/ili učinkovitost aktivacije receptora za 5-HT1 D receptor nego za 5-HT1 B i 5-HT1 F receptore.
The pharmaceutical composition or kit of parts for use according to any of the previous claims, wherein the compound is selected from the group consisting of zolmitriptan, sumatriptan, rizatriptan, naratriptan, almotriptan, frovatriptan and eletriptan, or pharmaceutically acceptable derivatives thereof. 
Farmaceutski pripravak ili set dijelova za uporabu prema bilo kojem od prethodnih zahtjeva, gdje se spoj odabire iz skupine koju čine zolmitriptan, sumatriptan, rizatriptan, naratriptan, almotriptan, frovatriptan i eletriptan, ili njihovi farmaceutski prikladni derivati.
The pharmaceutical composition or kit of parts for use according to any of the previous claims, wherein the 5-HT1A receptor agonist is selected from the group consisting of buspirone, alnespirone, binospirone, gepirone, ipsapirone, perospirone, tandospirone, befiradol, repinotan piclozotan, osemozotan, flesinoxan, flibanserin and sarizotan, or pharmaceutically acceptable derivatives thereof. 
Farmaceutski pripravak ili set dijelova za uporabu prema bilo kojem od prethodnih zahtjeva, gdje se agonist 5-HT1A receptora odabire iz skupine koju čine buspiron, alnespiron, binospiron, gepiron, ipsapiron, perospiron, tandospiron, befiradol, repinotan piklozotan, osemozotan, flesinoksan, flibanserin i sarizotan, ili njihovi farmaceutski prikladni derivati.
The pharmaceutical composition or kit of parts for use according to claim 7, wherein said one or more further active ingredients are selected from the group consisting of: Agents increasing the dopamine concentration in the synaptic cleft; agents which are used for treatment of Parkinson's disease; dopamine; L-DOPA; dopamine receptor agonists or pharmaceutically acceptable derivatives thereof; decarboxylase inhibitors; COMT (catechol-O-methyltransferase) inhibitors; NMDA (N-methyl-D-aspartate) antagonists; MAO-B inhibitors; serotonin receptor modulators; kappa opioid receptor agonists, GABA (gamma-aminobutyric acid) modulators, modulators of neuronal potassium channels and glutamate receptor modulators. 
Farmaceutski pripravak ili set dijelova za uporabu prema zahtjevu 7, gdje se navedena jedna ili više dodatnih djelatnih tvari odabire iz skupine koju čine: tvari koje povećavaju koncentraciju dopamina u sinaptičkoj pukotini; tvari koje se koriste za liječenje Parkinsonove bolesti; dopamin; L-DOPA; agonisti dopaminskih receptora ili njihovi farmaceutski prikladni derivati; inhibitori dekarboksilaze; COMT (katehol-O-metiltransferaza) inhibitori; NMDA (N-metil-D-aspartat) antagonisti; MAO-B inhibitori; modulatori serotoninskih receptora; agonisti kapa opioidnih receptora, GABA (gama-aminobutirična kiselina) modulatori, modulatori neuronskih kalijevih kanala i modulatori glutamat receptora.
The pharmaceutical composition or kit of parts for use according to any of the previous claims, wherein the movement disorder is selected from the group consisting of ataxia, dystonia, essential tremor, Huntington's disease, myoclonus, Rett syndrome, Tourette syndrome, Wilson's disease, chorea, Machado-Joseph disease, restless leg syndrome, spasmodic torticollis, geniospasm, and movement disorders caused by idiopathic disease, genetic dysfuntions, or infections or dysfunction of the basal ganglia. 
Farmaceutski pripravak ili set dijelova za uporabu prema bilo kojem od prethodnih zahtjeva, gdje se poremećaj kretanja odabire iz skupine koju čine ataksija, distonija, esencijalni tremor, Huntingtonova bolest, mioklonus, Rettov sindrom, Touretteov sindrom, Wilsonova bolest, korea, Machado-Josephova bolest, sindrom nemirnih nogu, spazmodički tortikolis, geniospazam, i poremećaj kretanja uzrokovan idiopatskom bolešću, genetičkom disfunkcijom ili infekcijama ili disfunkcijom bazalnih ganglija.
The pharmaceutical composition or kit of parts for use according to any of claims 7 to 10, wherein said one or more further active ingredients are to be administered simultaneously, sequentially or separately from said pharmaceutical composition or kit of parts. 
Farmaceutski pripravak ili set dijelova za uporabu prema bilo kojem od zahtjeva 7 do 10, gdje se jedna ili više dodatnih djelatnih tvari primjenjuje istodobno, uzastopce ili odvojeno od farmaceutskog pripravka ili seta dijelova.
The combination for use according to claim 14, wherein the additional therapeutic agent is selected from the group consisting of haloperidol, molindone, loxapine, thioridazine, molindone, thiothixene, pimozide, fluphenazine, trifluoperazine, mesoridazine, chlorprothixene, chlorpromazine, perphenazine, triflupromazine and zuclopenthixol. 
Kombinacija za uporabu prema zahtjevu 13, naznačena time da je dodatno terapeutsko sredstvo je odabrano iz skupine koju čine haloperidol, molindon, loksapin, tioridazin, tiotiksen, pimozid, flufenazin, trifluoperazin, mesoridazin, klorprotiksen, klorpromazin, perfenazin, triflupromazin i zuklopentiksol.
The method of claim 1, wherein the compound is 1-((6-(trans-4-tert-butylcyclohexyloxy)quinazolin-2-yl)methyl)piperidine-4-carboxylic acid, or a pharmaceutically acceptable salt thereof. 
Spoj prema zahtjevu 1, gdje je spoj 1-((6-(trans-4-tert-butilcikloheksiloksi)kinazolin-2-il)metil)piperidin-4-karboksilna kiselina ili njegova farmaceutski prikladna sol.
The method of claim 1, wherein the compound is 1-(1-(6-(trans-4-tert-butylcyclohexyloxy)naphthalen-2-yl)-2,2,2-trifluoroethyl)piperidine-4-carboxylic acid, or a pharmaceutically acceptable salt thereof. 
Spoj prema zahtjevu 1, gdje je spoj 1-(1-(6-(trans-4-tert-butilcikloheksiloksi)naftalen-2-il)-2,2,2-trifluoroetil) piperidin-4-karboksilna kiselina ili njegova farmaceutski prikladna sol.
The method of claim 1, wherein the compound is 1-((6-(spiro[4.5]decan-8-yloxy)naphthalen-2-yl)methyl)piperidine-4-carboxylic acid, or a pharmaceutically acceptable salt thereof. 
Spoj prema zahtjevu 1, gdje je spoj 1-((6-(spiro[4.5]dekan-8-iloksi)naftalen-2-il)metil)piperidin-4-karboksilna kiselina ili njegova farmaceutski prikladna sol.
The method of claim 1, wherein the compound is 1-((6-(cis-4-ethylcyclohexyloxy)naphthalen-2-yl)methyl)piperidine-4-carboxylic acid, or a pharmaceutically acceptable salt thereof. 
Spoj prema zahtjevu 1, gdje je spoj 1-((6-(cis-4-etilcikloheksiloksi)naftalen-2-il)metil)piperidin-4-karboksilna kiselina ili njegova farmaceutski prikladna sol.
The method of claim 1, wherein the compound is 1-((2-(trans-4-tert-butylcyclohexyloxy)quinolin-6-yl)methyl)piperidine-4-carboxylic acid, or a pharmaceutically acceptable salt thereof. 
Spoj prema zahtjevu 1, gdje je spoj 1-((2-(trans-4-tert-butilcikloheksiloksi)kinolin-6-il)metil)piperidin-4-karboksilna kiselina ili njegova farmaceutski prikladna sol.